UNSPSC 85762206: Revision of radioactive element in pericardial cavity, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of radioactive element in pericardial cavity, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0WWD41Z

UNSPSC 85762206 Revision of radioactive element in pericardial cavity, percutaneous endoscopic approach is a Commodity code that shows little relevant recent activity under its nominal clinical scope. The recent state and local opportunities tagged to this code—independent medical evaluation services, pharmacy benefit management, temporary health professional staffing, occupational medical surveillance, surgical benefits programs, and emergency medical services for detained youth—involve administrative healthcare purchasing, occupational health coordination, and benefits administration rather than the interventional cardiology procedure the code nominally describes. The mismatch suggests this code is either rarely used in state and local procurement for its intended purpose or has been misapplied to these health-system and benefits-related solicitations.

The issuing bodies across the recent opportunities span county human resources departments, county health systems, state transportation agencies, municipal retirement offices, and county juvenile justice divisions—a mix typical of state and local health benefits and occupational health procurement. Geographic activity appears in Arizona (Phoenix), California (Long Beach, Santa Clara County), Washington State (Department of Transportation and Ferries), Florida (Collier County), and Texas (Harris County). No opportunities directly address the code's stated scope of percutaneous endoscopic revision of radioactive elements in pericardial cavities. Vendors evaluating this code should treat it as inactive for direct clinical procurement purposes and flag the apparent classification misalignment for further review before committing resources to pursuit.